Epigral Limited (EPIGRAL) — Announcement

· NSE 🔴 High Importance Neutral
📢 Key Event
CRISIL reaffirms Epigral's long-term and short-term ratings
💡 Investor Takeaway
Investors can view the reaffirmed ratings as a sign of stable credit standing without any downgrade risk.

Epigral Limited received a rating review from CRISIL, reaffirming its long-term rating at AA/Stable and short-term rating at A1+ for a total bank loan facility of ₹1050 crores. The reaffirmations reflect stable credit quality and no changes to existing rating outlooks.

📄 View Original Announcement (PDF)

About Epigral Limited (EPIGRAL)

Chemicals · Chemicals & Petrochemicals · Listed on NSE

Market Cap: ₹5,247.71 Cr P/E: 14.6

View full EPIGRAL stock details →

📡 Get AI alerts when EPIGRAL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track EPIGRAL — Free

📊 More EPIGRAL filings

See all EPIGRAL filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when EPIGRAL files new disclosures

Track EPIGRAL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track EPIGRAL — Free

Free account · 2 AI queries/day